These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 23114910

  • 21. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain.
    Al Khaja KA, P Sequeira R, Damanhori AH.
    J Eval Clin Pract; 2005 Apr; 11(2):121-31. PubMed ID: 15813710
    [Abstract] [Full Text] [Related]

  • 22. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, Umeno Y, Okada K, Wakasugi K, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H.
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [Abstract] [Full Text] [Related]

  • 23. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H, Klose S, Lobmann R, Zehnder D.
    MMW Fortschr Med; 2006 May 25; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [Abstract] [Full Text] [Related]

  • 24. [Type II diabetes and hypertension].
    Peters A, Kerner W.
    Med Klin (Munich); 1996 Oct 15; 91(10):640-5. PubMed ID: 9019641
    [No Abstract] [Full Text] [Related]

  • 25. Microvascular benefits of hypertension and glucose control in type 2 diabetes.
    van Rensburg BW.
    Cardiovasc J Afr; 2008 Oct 15; 19(4):179-80. PubMed ID: 18776957
    [No Abstract] [Full Text] [Related]

  • 26. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension.
    Marcadenti A, Fuchs SC, Moreira LB, Wiehe M, Gus M, Fuchs FD.
    Am J Hypertens; 2011 Feb 15; 24(2):175-80. PubMed ID: 20885370
    [Abstract] [Full Text] [Related]

  • 27. Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary care.
    Schäfer HH, de Villiers JD, Lotze U, Sivukhina E, Burnier M, Noll G, Theus GR, Dieterle T.
    Clin Exp Hypertens; 2013 Feb 15; 35(7):496-505. PubMed ID: 23301512
    [Abstract] [Full Text] [Related]

  • 28. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus].
    Zonis BIa, Volkova NI, Sokolov OIu.
    Ter Arkh; 2000 Feb 15; 72(2):53-5. PubMed ID: 10717928
    [Abstract] [Full Text] [Related]

  • 29. [Vascular damage decides prognosis of type 2 diabetic patients. Lowering blood glucose is not enough].
    MMW Fortschr Med; 2002 May 02; 144(18):65. PubMed ID: 12422717
    [No Abstract] [Full Text] [Related]

  • 30. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF, Mann JF.
    Nephrol Dial Transplant; 2008 Nov 02; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract] [Full Text] [Related]

  • 31. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM, Weir MR.
    Postgrad Med; 2011 May 02; 123(3):109-21. PubMed ID: 21566421
    [Abstract] [Full Text] [Related]

  • 32. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
    García-Donaire JA, Segura J, Cerezo C, Ruilope LM.
    Blood Press; 2011 Dec 02; 20(6):322-34. PubMed ID: 21936729
    [Abstract] [Full Text] [Related]

  • 33. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
    Crouch MA.
    Consult Pharm; 2010 Oct 02; 25(10):686, 688. PubMed ID: 21030359
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.
    Diabet Med; 2005 Oct 02; 22(10):1394-400. PubMed ID: 16176202
    [Abstract] [Full Text] [Related]

  • 38. [Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].
    Marx N, Blessing E.
    Dtsch Med Wochenschr; 2007 May 11; 132(19):1034-8. PubMed ID: 17476633
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of hypertension in diabetes: what is the best therapeutic option?
    Aksnes TA, Skårn SN, Kjeldsen SE.
    Expert Rev Cardiovasc Ther; 2012 Jun 11; 10(6):727-34. PubMed ID: 22894629
    [Abstract] [Full Text] [Related]

  • 40. Treatment of metabolic syndrome.
    Wagh A, Stone NJ.
    Expert Rev Cardiovasc Ther; 2004 Mar 11; 2(2):213-28. PubMed ID: 15151470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.